2021
DOI: 10.1017/s0022215120002753 View full text |Buy / Rent full text
|
|

Abstract: Background Since the start of the coronavirus disease 2019 pandemic, transnasal humidified rapid-insufflation ventilatory exchange (‘THRIVE’) has been classified as a high-risk aerosol-generating procedure and is strongly discouraged, despite a lack of conclusive evidence on its safety. Methods This study aimed to investigate the safety of transnasal humidified rapid-insufflation ventilatory exchange usage and its impact on staff members. A prospective study was conducted on all transnas… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals